FT
Frank E Thomas

Frank E Thomas insider trades: Larimar Therapeutics (LRMR) stock buys and sales

Larimar Therapeutics Last trade Feb 27, 2026 72 Form 4 filings
$0
Sold, last 12 months
0 sales
$25K
Bought, last 12 months
1 buy
12
Open-market trades
since 2007
6
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Frank reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 27, 2026LRMR↑ Buy$25K
Feb 14, 2024LRMR↑ Buy$22K
Apr 1, 2022ORTX↑ Buy$7K
Aug 5, 2015AMAG↓ Sell$1.0M
Jun 4, 2015AMAG↓ Sell$1.4M
Jan 3, 2013AMAG↓ Sell$156K
Nov 30, 2012AMAG↓ Sell$75K
Apr 2, 2012AMAG↑ Buy10b5-1$8K
Mar 1, 2012AMAG↑ Buy10b5-1$8K
Feb 1, 2012AMAG↑ Buy10b5-1$8K
Jan 3, 2012AMAG↑ Buy10b5-1$10K
Aug 22, 2007CRTX↑ Buy$11K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LRMR insiders

Open-market trades in the last 12 months

About Frank E Thomas's insider trades

Frank E Thomas is an insider at Larimar Therapeutics (LRMR). Since Aug 22, 2007, Frank has reported 8 open-market purchases worth $99K and 4 sales worth $2.6M on SEC Form 4. In the last 12 months: 1 buy ($25K).

Their filings also include grants and awards (47 filings), option exercises (9 filings), shares withheld for taxes (6 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LRMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.